These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31377744)

  • 41. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
    Ma K; Chen S; Chen X; Yang C; Yang J
    World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of CD155 expression in human pancreatic cancer.
    Nishiwada S; Sho M; Yasuda S; Shimada K; Yamato I; Akahori T; Kinoshita S; Nagai M; Konishi N; Nakajima Y
    Anticancer Res; 2015 Apr; 35(4):2287-97. PubMed ID: 25862891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.
    Zhu H; Hu X; Feng S; Gu L; Jian Z; Zou N; Xiong X
    Front Immunol; 2022; 13():946692. PubMed ID: 35928818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.
    Ma K; Chen X; Liu W; Yang Y; Chen S; Sun J; Ma C; Wang T; Yang J
    Sci Rep; 2021 Oct; 11(1):20839. PubMed ID: 34675316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD155 and its receptors in cancer immune escape and immunotherapy.
    Zhou R; Chen S; Wu Q; Liu L; Wang Y; Mo Y; Zeng Z; Zu X; Xiong W; Wang F
    Cancer Lett; 2023 Oct; 573():216381. PubMed ID: 37660884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
    Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
    Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poliovirus receptor CD155-targeted oncolysis of glioma.
    Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
    Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
    Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
    Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
    Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
    Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of PD-L1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas.
    Jha P; Manjunath N; Singh J; Mani K; Garg A; Kaur K; Sharma MC; Raheja A; Suri A; Sarkar C; Suri V
    Neuropathology; 2019 Dec; 39(6):413-424. PubMed ID: 31625205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients.
    Liang T; Wang X; Wang F; Feng E; You G
    World Neurosurg; 2019 Dec; 132():e455-e462. PubMed ID: 31470166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
    Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
    Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD155 as an emerging target in tumor immunotherapy.
    Wu JW; Liu Y; Dai XJ; Liu HM; Zheng YC; Liu HM
    Int Immunopharmacol; 2024 Apr; 131():111896. PubMed ID: 38518596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer.
    Freed-Pastor WA; Lambert LJ; Ely ZA; Pattada NB; Bhutkar A; Eng G; Mercer KL; Garcia AP; Lin L; Rideout WM; Hwang WL; Schenkel JM; Jaeger AM; Bronson RT; Westcott PMK; Hether TD; Divakar P; Reeves JW; Deshpande V; Delorey T; Phillips D; Yilmaz OH; Regev A; Jacks T
    Cancer Cell; 2021 Oct; 39(10):1342-1360.e14. PubMed ID: 34358448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.
    Hwang K; Koh EJ; Choi EJ; Kang TH; Han JH; Choe G; Park SH; Yearley JH; Annamalai L; Blumenschein W; Sathe M; McClanahan T; Jung H; Wang KC; Kim SK; Kim CY
    J Neurooncol; 2018 Sep; 139(2):281-291. PubMed ID: 29730815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.